Premium
Measuring the Value of Pharmacogenomics Evidence
Author(s) -
Patrinos GP,
Mitropoulou C
Publication year - 2017
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.743
Subject(s) - pharmacogenomics , modalities , psychological intervention , value (mathematics) , medicine , intensive care medicine , computer science , pharmacology , psychiatry , social science , machine learning , sociology
In recent years, there is a growing need to measure the value of pharmacogenomics testing so that policymakers are well informed to decide about adopting and reimbursing pharmacogenomics testing, prioritizing pharmacogenomics research and development, and encouraging the application of companion diagnostics. Presently, there are limited economic evaluation studies of genome‐guided treatment modalities that would allow decision‐makers to comparatively assess the value and clinical utility of such interventions.